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arrhythmias &antiarrhythmic drugs 
＜イオンチャネル の分子薬理学＞に続いて 
• （ギリシャ語） A + rhythm 
• 正常な心拍動から逸脱した心筋の脱分極
からなる。 




 分子薬理学 柳澤輝行 
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 Distribution of the molecular functions of 26,383 human genes.  Science (2001) Fig. 15.  
22,000 genes (2004) 
Science, Vol 306, Issue 5693, 79-86 , 1 October 2004 
Figure S4. (eukaryotic cluster of orthologous groups)  






















乳酸・Ｈ の産生 + 








small oxygen debt: extract about 75% 
of available oxygen 
‘tachycardia’– very harmful 
Lead V4 at rest (top) and after 4.5 min of exercise (bottom).  
There is 0.3 mV of horizontal ST-segment depression,  
indicating a positive test for ischemia.  
1 sec 
1 mV 








the outer ventricular 
layer (transmural or 
epicardial injury) 
心筋梗塞初期、攣縮性狭心症 














Ischemia-induced ST changes 
 Ischemia (SG-75)-induced VF 





























心室細動 ventricular fibrillation  





R on T現象 
不整脈判読トレーニング 
不整脈と抗不整脈薬 
正常拍動Normal cardiac rhythm  
• site of origin of the impulse  SA node 
 
• its rate or regularity 60 - 100 beat/min 
変動が10%以下 
• its conduction.  normal pathway 
 
• normal rate (beats/min):  SA node (100);   AV 













































































期SNP.      図5-140 新臨床内科学 8th 












Mechanisms of arrhythmias  
Disturbances of impulse formation  
 興奮生成の異常 
  正常自動能の亢進あるいは低下 
  異常自動能の発生 
 
Disturbances of impulse conduction 
 興奮伝導の異常 











































Disturbances of impulse formation  
興奮生成の異常 i)  
increased pacemaker rate  図4-20の逆 
1) less negative maximum diastolic potential 
2) increase of the slope of diastolic (phase 4) 
depolarization 
3) less positive threshold potential 
4) shortening of the action potential duration (APD)  
 
例 sympathetic and parasympathetic effects on SA node 
（参照、標準生理学）  
Disturbances of impulse formation  
興奮生成の異常 ii)  
Hypokalemia; ectopic pacemaker generation  
 due to the decrease in gK   (inherent in K
+ 
channels) 
Hypokalemia results in an increased risk of early 
and delayed afterdepolarization (EAD, DAD), 
and ectopic beat 
Hyperkalemia stabilizes the membrane close to 
the EK (due to the increase in gK )  
Disturbances of impulse formation  
興奮生成の異常 iii)  
Triggered pacemaker activity due to intracellular Ca 
overload 図4-19C） 




 Transient inward current一過性内向き電流 
 oscillation of [Ca2+]i; Ca-induced Ca release 
 spontaneous Ca release from SR through ryanodine R. 











DADによるトリガー活動, Ryanodine 受容体 
DAD 
Disturbances of impulse formation 
興奮生成の異常 iv)  
EAD: early afterdepolarization (arises from the plateau)
早期後脱分極 
図4-19D) 
EAD at various membrane potentials 
APDの延長がある。多くの場合、除拍。 
a) inhibition of K+ current (Cs+, Ba2+, low K+e) 
b) modulation of Na+ current (aconitine, veratridine)  
c)enhancement of Ca2+ current (isoproterenol, Bay K 8644) 
 










Relationship of the ventricular action potential (B) 
to the electrocardiogram (ECG) (A)  
EAD 
Early afterdepolarization 
Prolonged APD → Long QT syndrome 
活動電位持続時間APD 









型type  染色体 欠陥遺伝子 イオンチャネル・ 変異機能1 
      タンパク質 
LQT-12  11 KCNQ1  IKs  低下 
LQT-2  7 HERG (KCNH2) IKr  低下 
LQT-3  3 SCN5A  INa  亢進 
LQT-4  4 アンキリン-B 3  低下 
LQT-5  21 KCNE1 (minK) IKsβ  低下 
LQT-6  21 KCNE2 (MiRP1) IKrβ  低下 
LQT-74  17 KCNJ2  IKir  低下 
Brugada症候群 3 SCN5A  INa  低下 
PCCD5  3 SCN5A  INa  低下 
家族性心房細動 11 KCNQ1  IKs  亢進 
1変異による機能変化，低下loss of function; 亢進gain of function. 





Disturbances of impulse conduction 
 興奮伝導の異常 i)  
AV block; SA block (sick sinus syndrome) 
Bradycardia 徐拍 "Bradyarrhythmia"  




Disturbances of impulse conduction 
 興奮伝導の異常 ii) 





















リエントリ reentry の条件 p.151 
1) obstacle to homogeneous conduction, 
establishing a circuit 均一伝導の障害、旋回路
の形成。 
2) unidirectional block in the circuit (depressed 
conduction) 一方向性ブロック。 




Therapeutic strategy against reentry 
1) Lengthening of the refractory period or APD (IK 
block)  
2) Conduction around the circuit aslow, bweek, clate by 
depression of INa or ICa (esp. AV node) 
 a bidirectional block;  
 b failed conduction;  
 c collision with the next regular beat 
3) if conduction is too rapid: bidirectional conduction, 
refractory  
 
== usually 1) or 2) mechanism 
Disturbances of impulse conduction 
 興奮伝導の異常iii)  








catheter ablationが主になっている。  
ＷＰＷ症候群の心電図所見（ＷＰＷ型心電図） 
































































★ ★ ★ 
仙台市立病院 石田明彦先生 
Therapeutic mechanisms of 
action against arrhythmias 
A. Na+ channel blockade (Class 1)  
 - modulated receptor theory 
 - dynamism of blockade 
B. β Blockade (Class 2)  
C. K+ channel blockade(Class 3) 
            prolongation of refractory period (APD)  
D. Ca2+ channel blockade (Class 4)  
E. Miscellaneous 
局所麻酔薬とTTXのNa+ チャネル遮断様式 






  LA  
(中性) 
細胞内 
Na+チャネル   
（非特異的・低親和性遮断） 
Na + 電流 
細胞膜 




















A. Na channel blocking drugs  
(Class 1)  
1) Quinidine (Class 1A) 
• アンデス山脈原産のアカネ科キナノキ（Cinchona） 
a. Cardiac effects 
• Blocks Na+ channel in the activated state 
• Slow kinetics recovery from block 
• Prolong APD → prolong QT (block of KV channel ) 
• Ca2+ channel blocking action 
b. Therapeutic use: nearly every form of arrhythmias 
Quinidine -- Side effects 
1. Quinidine syncope 失神：torsade de pointesトル
サード: a drug-induced rapid, disorganized 
ventricular tachycardia resembling ventricular 
fibrillation, which usually terminates spontaneously, 
associated with a striking prolongation of QT 
interval 
2. Sinus depression esp. in elderly with sick sinus 
syndrome [due to Ca channel blocking action] 
3. Hypotension [due to Ca channel blocking action]  
Quinidine -- Side effects 
4. Side effects due to anitmuscarinic effects 
(atropine-like, inhibition of vagus n.) 
 a. Sinus tachycardia 
 b. Facilitation of AV nodal conduction;  
• increased ventricular rate in accompanying with atrial 
fibrillation or flutter (paradoxical tachycardia) 
• to prevent: preadministration of digitalis, β-blocker or 
verapamil 
5. GI tract; diarrhea, nausea, vomiting 
• Cinchonism (headache, dizziness, tinnitus)  
• Like quinidine; Slow kinetics recovery from block 
• anitmuscarinic effects (more marked than 
quinidine),  
• structurally likes isopropamide; all of the side 
effects of atropine 
 
2) Disopyramide (Class 1A) 




3) Procainamide (Class 1A) 
• procaine (LA) 'amide' (KdI = 370 mM) 
• Like quinidine; Slow kinetics recovery from block 
• without  anitmuscarinic effects  
• Side effects; heart failure; lupus erythematosus-
like syndrome。slow acetylator に多い。    
• 肝臓で N-acetylation 代謝される。  





3群抗不整脈作用, prolongation of APD 
K+ チャネル遮断作用 
4) Propafenone#, Flecainide, 
Pilsicainide* (Class 1C) 
• Blocks Na channel in the activated state (like quinidine);  
no effect on APD  
• #incidence of heart failure (9.3%) 
• *Very slow kinetics recovery from block, l→R = 0.05 
/msec 
• premature ventricular contraction; very effective 
• without  anitmuscarinic effects  
• Myocardial infarction with arrhythmias (long term 
administration) higher mortality than placebo   CAST 
study: New Engl. J. Med. 321: 406-412, 1989.  (新薬理学入門 
















しくは心停止であった。 CAST study (N Engl J Med 321: 406-412, 
1989)    
5) (Class 1B) Lidocaine (i.v. administration); 
Mexiletine (p.o. administration) 
• Blocks both activated and inactivated Na channels 
• Fast kinetics recovery from block; l→R = 1 /msec 
• Shorten APD 
• no suppression of normal conduction,  
• inhibition of the ectopic beat with short coupling intervals 
(< 500 ms) 
• selective inhibition of the ectopic beat at high basal 
frequency 
• very effective for suppressing arrhythmias associated with 
depolarization (ischemia, myocardial infarction, digitalis 
toxicity)  
Toxicity of class 1 antiarrhythmic 
drugs  
1) suppression of normal conduction with use-
dependency 
2) prolongation of QRS (proarrhythmic, drug-
induced arrhythmias) hyperkalemia increases 
the depressant effect of class 1  
  対策 by increasing serum pH (reduction of [K+]o) 
to reduce the depressant effect of class 1 at 
normal or high [K+]o  
3) Convulsion けいれん 
Modulated receptor theory p.152 
Channel blocking drugs have high affinity for 
activated or inactivated channels but low affinity 




“modulated receptor theory” とは、 「チャネル遮断





Dependence of Na channel function on the membrane 
potential preceding the stimulus (Vh).   
The shift in the curve illustrates the effect of a typical local 
anesthetic antiarrhythmic drug.  
Resting membrane potential 
Drug 
Control 
Channels available,  
percent of maximum 
Drug 
Control 
Resting membrane potential 




C t1 t2 tn 
“recovery” 
The time constant for recovery from inactivation 
after repolarization also depends on the resting 
potential. 
(note logarithmic scale) 
‘state-dependent block` 
活性化 (A)、不活性化 (I)状態 
• 'voltage-dependent block' esp. I 
• 'frequency-dependent block' esp. A 
• 'use-dependent block'   esp. A 
 
• fast tachycardia (many channels in A & I) 
• loss of resting potential (many channels in I) 
• longer APD (many channels in A & I,   
   Ventricle > Atrium)  
• Cf. Local anestetics blockade （２年生） 
Na+ channel  
D D D 
R A I 
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Slow kinetic (recovery from block ) drugs  
•Slow kinetics (disopyramide); quinidine: intemed. 
•Very slow kinetics (flecainide, pilsicainide)  
i. merits  
•inhibition of the ectopic beat異所性興奮at low frequency 
of sinus rhythm  
•inhibition of the ectopic beat with long coupling intervals
連結期 
ii. demerits 
•suppression of normal conduction with use-dependency使
用依存性に正常拍動を抑制する。prolongation of QRS 
(proarrhythmic催不整脈作用) 
Fast kinetics (lidocaine, mexiletine) 
i. merits  
• no suppression of normal conduction,  
• inhibition of the ectopic beat with short coupling intervals 
 (< 500 ms) 




• no inhibition of the ectopic beat with long coupling 
intervals 
• Less or not effective to atrial arrhythmias 
B. b Adrenoceptor blocking drugs 
(Class 2) 
b1-blockers (metoprolol, bisoprolol, carvedilol) are 
better than propranolol 
esmolol (short acting, intraoperative, acute arrhythmias) 
• prevent recurrent infarction and sudden death in 
Pts recovering acute myocardial infarction 
• Arrhythmias with chronic heart failure 
• Thyrotoxicosis  甲状腺機能亢進症；老人の症状
は不整脈 (特に、Af) のみの場合あり。 
• Sotalol ( + Class 3 action: prolongation of APD) 
 
β遮断薬 ←イソプロテレノール 












C. Class 3 antiarrhythmic drugs 
• Amiodarone, Sotalol, Nifekalant, Vernakalant 
• Prolongation of APD and refractory period; prolong QT 
interval 
• Amiodarone (all actions of Class 1A, 2, 3, 4) 
noncompetitive blockade of b-receptor  
• Very effective against both supraventricular and 
ventricular arrhythmias 
• Wolff-Parkinson-White syndrome (WPW) 
– accessory conduction pathway (Kent bundle) 
#Vernakalant (Kur, KACh, Ito抑制；心房細動, AVRO試験) 
Pharmacokinetics of amiodarone 
(Melmon & Morreli's Clinical Pharmacology 3rd Ed.)  
• Oral bioavailability (F)    0.22 - 0.86 
• Time to maximum conc. (Tmax)   3 - 7 hr 
• Volume of distribution (Vd)   18 - 148 L/kg 
• Protein binding     96% 
• Clearance  (% renal < 1) 100 - 175 ml/min  
• half-life    t1/2a (redistribution)  NR 
   t1/2b (clearance)  2.5 - 10 days (initial) 
     40 - 55 days (terminal) 
• Therapeutic range     1 - 2.5 mg/L 
左 CAMIAT Studyの成績.1202人の心筋梗塞後の心室性期外収縮を認め
る患者でのアミオダロン投与は、心室細動・不整脈に関してアミオダロン群が良
好であった。 （Lancet 1997;349: 675） 
右  CHF-STATの成績. うっ血性心不全と無症候性心室性不整脈を有する
患者に対するアミオダロン投与は、生命予後に関して全体ではプラセボ群との差
はなかったが、非虚血性の心筋症患者に関して検討したところ、有意にアミオダ
ロン群の生命予後は良好であった。 （N Engl J Med 1995;333: 77） 
Toxicity of amiodarone 
• Its toxicity limits its clinical usefulness 他の抗不整脈薬
が無効で、危険な不整脈の時に用いる。 
• Deposition in every tissue in all cases with long term 
administration 
• Corneal deposition (yellowish-brown microcrystals) 
• Photodermatitis 
• Paresthesias 異常感覚, tremor 振戦, ataxia 失調, 
headache 
• Thyroid dysfunction; hypo- or hyper- 
 化学構造を見るとI ヨウ素を含むため 










Sotalol, Nifekalant, Vernakalant 
逆頻度依存性活動電位延長 































スIII群薬の理想的な頻度依存性を示している。 (Circulation 81: 686, 1990) 
D. Class 4 antiarrhythmic drugs 
• Non-vasoselective Ca2+ channel blockers 
– Cf. vascular selective Ca2+ channel blockers (DHP Ca 
antagonists: nifedipine, amlodipine, …) 
• Verapamil  (anti-anginal drug) 
• Diltiazem (anti-anginal, antihypertensive drug) 
• Bepridil  (+ 1, 3 actions) 
• Paroxysmal supraventricular tachycardia 
 suppression of AV conduction (Ca2+ current)  
E. Miscellaneous antiarrhythmic drugs 
1) Adenosine, ATP  
• supraventricular tachycardia 
• increased gK (Gi protein-coupled A1R →KGIR 
channel (i.e. KACh) 開) 
• inhibition of cAMP-induced Ca2+ influx 
2) Magnesium 
• digitalis-induced arrhythmias 
(hypomagnesemia) 
• torsade de pointes 
• acute myocardial infarction  
E. Miscellaneous antiarrhythmic drugs 
3) Potassium 
• Hypokalemia results in an increased risk of EAD, 
DAD, and ectopic pacemaker activity, especially in 
the presence of digitalis. 
• normalizing potassium gradients and pools in the 
body 
4) Digitalis as an Antiarrhythmic (via vagal n. st.) 
• 心房粗動atrial flutter →心房細動atrial fibrillation 
• 洞結節性および房室結節性リエントリ  
Trigger  Modulating factors 















































a) 房室結節内伝導（Caチャネル依存性）  
 あるいは  
b) ケント束伝導（Naチャネル依存性）の抑制 
a) Caチャネル  
b) Naチャネル 











心房細動； 心房内血栓； 脳塞栓症 
心房細動は認知症の独立した危険因子 









ムの40億年を渉猟する(1999)    
柳澤輝行、今野俊宏：カリウムチャネルの分子薬理学．
臨床麻酔 30(4): 659-667 (2006) 
 2011.5.25 薬理学II   
抗不整脈薬 アンケート課題４） 
Ventricular cellの活動電位に対す
る抗不整脈薬IB, III, IV群薬
の作用をコントロールと比較して
それぞれ図示して下さい。 
 
Ib 
Ia, III 
IV 
100 msec 
40 mV 
